Progesterone

Spezifikationen

57-83-0CAS-Nummer

200-350-6EG-Nummer

(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-oneIUPAC-Name

C21H30O2Chemische Formel

314.5 g/molMolekulargewicht

progesterone; 57-83-0; Pregn-4-ene-3,20-dione; Agolutin; Progestin; Crinone; Utrogestan; Luteol; Gestormone; Glanducorpin; Prometrium; Syngesterone; Corlutin; Cyclogest; Gestone; 4-Pregnene-3,20-dione; Corlutina; Corluvite; Flavolutan; Fologenon; Gynolutone; Hormoflaveine; Hormoluton; Lucorteum; Luteostab; Lutociclina; Lutocyclin; Pregnenedione; Progestasert; Progesterol; Progesteronum; Progestone; Progestron; Corporin; Gesterol; Gestron; Gynlutin; Luteodyn; Luteogan; Luteopur; Luteosan; Luteovis; Lutidon; Nalutron; Lutin; Lutocyclin M; Bio-luton; Lipo-Lutin; Luteocrin normale; Methylpregnone; Progestosol; Progestronol; Syngestrets; Lingusorbs; Luteinique; Lutocylin; Lutoform; Lutogyl; Lutromone; Membrettes; Piaponon; Primolut; Progekan; Prolets; Prolidon; Proluton; Protormone; Syntolutan; Lutren; Lucorteum Sol; Prochieve; Prolutone; Synovex S; Endometrin; Gesterol 100; Gynoluton; Projestaject; Percutacrine Luteinique; 17alpha-Progesterone; Progeston; Pregnene-3,20-dione; Gestiron; Progestogel; 3,20-Pregnene-4; Akrolutin; Progestol; Luteum; Crinone progesterone gel; NSC-9704; (S)-Progesterone; Progesterona; Progesteron; Vitarrine; Gelbkoerperhormon; beta-Progesterone; DTXSID3022370; (S)-4-Pregnene-3,20-dione; Delta(4)-pregnene-3,20-dione; (S)-Pregn-4-en-3,20-dione; Lutogynon; Progesterone, micronized; 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione; NSC-64377; MILPROSA; 4G7DS2Q64Y; CHEBI:17026; NSC9704; delta(Sup4)-pregnene-3,20-dione; (8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; NSC64377; U 3672; DTXCID902370; Natural Progesterone; delta4-Pregnene-3,20-dione; Syngestrone; Lutigest; Progesta-care; Progesto-Life; Lutocylin M; Progesterone Combo; Serenity for women; Progesterone Phenolic; Synthetic Progestagen; Progesterone 1538; (8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta(a)phenanthren-3-one; RefChem:6165; Therapeutic Progesterone; P25 Progesterone Cream; P50 Progesterone Cream; P75 Progesterone Cream; EAZI-BREED CIDR Sheep; EAZI-BREED CIDR Cattle; P75 Lav Progesterone Cream; Advanced Formula Progesto-Life; CHEBI:59826; EAZI-BREED CIDR Sheep Insert; EAZI-BREED CIDR Cattle Insert; G03DA04; DTXCID801775313; P75 Maxx with Retinol All Natural Progesterone 75 Cream; (1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadec-6-en-5-one; 200-350-6; DTXSID001346637; Lutocylol; Lutex; Gesterol 50; Colprosterone; Cyclogesterin; Prolutin; Lugesteron; Lutocuclin M; Luteol (VAN); .beta.-Progesterone; Percutacrine; Progeffik; Utrogest; Estima; Progesteronum [INN-Latin]; Progesterona [INN-Spanish]; delta(sup 4)-Pregnene-3,20-dione; C21H30O2; CCRIS 533; Prontogest; Progesterone (Standard); 17.alpha.-Progesterone; HSDB 3389; Progesterone [Progestins]; 4-Pregnen-3,20-dione; AI3-51682; Prometrium (TN); Pregn-4-en-3,20-dione; Crinone (TN); 6alpha-Methylpregn-4-en-17alpha-ol-3,20-dione; .delta.4-Pregnene-3,20-dione; Pregn-4-ene-3,20-dione, 17alpha-hydroxy-6alpha-methyl-; component of Cyclogesterin; MFCD00003658; .delta.(sup4)-Pregnene-3,20-dione; CHEMBL103; D4-Pregnene-3,20-dione; MLS000028517; (8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; NCGC00015785-04; SMR000058345; 6.alpha.-Methylpregn-4-en-17.alpha.-ol-3,20-dione; 17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione; 17a-Progesterone; Duraprogen; Pregesterone; Progestan; Pregn-4-ene-3,20-dione, 17.alpha.-hydroxy-6.alpha.-methyl-; (1S,10S,11S,14S,15S,2R)-14-acetyl-2,15-dimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0 <11,15>]heptadec-6-ene; SMR000653542; CIDR; Progesterone (Prometrium); WLN: L E5 B666 OV MUTJ A1 E1 FV1; SR-01000000088; SR-01000076054; NSC 9704; EINECS 200-350-6; NSC 64377; Pregn-4-ene-3, 17.alpha.-hydroxy-6.alpha.-methyl-; BHR-100; UNII-4G7DS2Q64Y; Progestrel; Lipolutin; Lutinus; HUMAN SERUM (progesterone); Progesterone RS; Progesterone CRS; 1dbb; CAS-57-83-0; Progesterone [USP:INN:BAN:JAN]; racemic progesterone; Prestwick_411; Progesterone solution; mpp22; 2aa6; 4bb2; Opera_ID_292; Progesterone, >=99%; Prestwick0_000477; Prestwick1_000477; Prestwick2_000477; Prestwick3_000477; Spectrum5_002053; PROGESTERONE [MI]; Cyclogesterin (Salt/Mix); PROGESTERONE [INN]; PROGESTERONE [JAN]; bmse000482; Epitope ID:116051; EC 200-350-6; PROGESTERONE [HSDB]; SCHEMBL7671; ?4-Pregnene-3,20-dione; PROGESTERONE [VANDF]; BIDD:PXR0094; Lopac0_000895; BSPBio_000614; PROGESTERONE [MART.]; MLS000758277; MLS001074187; MLS001423982; MLS002222367; BIDD:ER0547; P0130_SIGMA; PROGESTERONE [USP-RS]; PROGESTERONE [WHO-DD]; PROGESTERONE [WHO-IP]; SPBio_002553; .delta.-Pregnene-3,20-dione; BDBM8903; BPBio1_000676; GTPL2377; Hydroxyprogesterone Caproic acid; orb1310573; orb3025169; SCHEMBL7610853; SCHEMBL8711607; HY-N0437R; Progesterone (JP18/USP/INN); BHR-310; ETI-411; MSK2223; PROGESTERONE [GREEN BOOK]; 1a28; 1h60; HMS1569O16; HMS2051O05; HMS2090J07; HMS2096O16; HMS2230F23; HMS2233P11; HMS3262D12; HMS3713O16; Pregnene, 3,20-dione-delta^4-; PROGESTERONE [ORANGE BOOK]; PROGESTERONE [EP MONOGRAPH]; Progesterone in human serum (high); BIJUVA COMPONENT PROGESTERONE; HY-N0437; PROGESTERONE [USP MONOGRAPH]; Tox21_113157; Tox21_201792; Tox21_300307; Tox21_500895; AC-700; CMC_13406; EBC-06111; LMST02030159; MSK2223-100A; Progesterone, 1mg/ml in Acetonitrile; PROGESTERONUM [WHO-IP LATIN]; s1705; SBB012538; AKOS015894908; MSK2223-1000A; Pregn-4-ene-3,20-dione (Standard); Progesterone; 4-Pregnene-3,20-dione; CCG-100766; CS-1937; DB00396; DR-2011; FD12045; FP27173; LP00895; NC00016; SDCCGSBI-0050870.P002; Progesterone 1.0 mg/ml in Acetonitrile; NCGC00022185-03; NCGC00022185-04; NCGC00022185-05; NCGC00022185-06; NCGC00022185-07; NCGC00022185-08; NCGC00022185-09; NCGC00022185-10; NCGC00022185-11; NCGC00022185-12; NCGC00022185-14; NCGC00022185-21; NCGC00090798-01; NCGC00090798-02; NCGC00254120-01; NCGC00259341-01; NCGC00261580-01; (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one; AS-12660; CPD000058345; NCI60_042166; ST069329; FE-999913; CS-0694805; EU-0100895; NS00010899; P0478; P6854; T0478; (14beta,17alpha)-pregn-4-ene-3,20-dione; Progesterone, meets USP testing specifications; Progesterone, Vetec(TM) reagent grade, 98%; C00410; D00066; P 0130; Q26963; S00293; Progesterone Solution in Acetonitrile, 100ug/mL; Progesterone, VETRANAL(TM), analytical standard; F374675; Progesterone Solution in Acetonitrile, 1000ug/mL; SR-01000000088-5; SR-01000000088-6; SR-01000076054-1; SR-01000076054-4; BRD-K64994968-001-03-6; 32104FB6-BF81-4F6E-83C2-024DEEAEB272; Z1501485353; Progesterone, British Pharmacopoeia (BP) Reference Standard; Progesterone, powder, BioReagent, suitable for cell culture; Progesterone, European Pharmacopoeia (EP) Reference Standard; Progesterone, gamma-irradiated, BioXtra, suitable for cell culture; Progesterone, United States Pharmacopeia (USP) Reference Standard; Progesterone-Water Soluble, powder, BioReagent, suitable for cell culture; Progesterone for peak identification, European Pharmacopoeia (EP) Reference Standard; Progesterone for system suitability, European Pharmacopoeia (EP) Reference Standard; Progesterone, Pharmaceutical Secondary Standard; Certified Reference Material; (1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one; 137940-28-4; Progesterone MicronizedSynonyme